Gerard Silvestri to Erlotinib Hydrochloride
This is a "connection" page, showing publications Gerard Silvestri has written about Erlotinib Hydrochloride.
Connection Strength
0.066
-
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest. 2005 Dec; 128(6):3975-84.
Score: 0.066
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.